PO.ET08.03 · 实验与分子治疗
短暂暴露于TTFields通过下调DNA修复通路增强胶质母细胞瘤的放射应答
Short exposure to TTFields potentiates radiation response in glioblastoma via downregulation of DNA repair pathways
该海报暂无可下载的资料
AACR 官方页面
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
背景:肿瘤电场治疗(TTFields)通过施加低强度交变电场来破坏对癌细胞分裂至关重要的细胞过程,是一种经FDA批准用于新诊断和复发性胶质母细胞瘤(GBM)患者的治疗方式。除其已确立的抗有丝分裂作用外,TTFields已被证明可干扰DNA损伤修复通路,提示其与放射治疗(RT)具有潜在的协同作用。在本研究中,我们探讨了短暂暴露于TTFields是否能使GBM细胞对放射敏感化。
方法:将U87-MG GBM细胞暴露于2 Gy放射、TTFields(200 kHz,2小时),或先TTFields后放射,并检测集落形成。通过PCR检测对照组和TTFields处理细胞的RNA提取物中DNA损伤应答基因的变化。Western blot分析评估DNA修复基因FANCD2、FANCJ、FANCA、FANCB、BRCA1和BRCA2的蛋白水平变化。将C57BL/6小鼠颅内植入GL261-mCherry胶质瘤细胞,并在植入后第17天通过MRI确认肿瘤生长。随后将小鼠随机分组接受TTFields(200 kHz)、RT(6 Gy)或两种方式联合并采用不同的时序:RT前TTFields、RT后TTFields,或RT前后均TTFields。取肿瘤制备单细胞悬液,通过流式细胞术使用gammaH2AX染色对DNA损伤进行定量。
结果:单独短暂暴露于TTFields不足以减少细胞的集落形成。然而,当在RT之前施加TTFields时,集落形成相对于单独RT有所减少。TTFields处理的细胞表现出与DNA损伤修复相关的基因和蛋白的下调。在小鼠中,RT后施加TTFields相对于单独RT对肿瘤DNA损伤水平的影响可忽略不计,而RT前施加TTFields则导致肿瘤细胞内DNA损伤增加、DNA修复蛋白表达降低,同时肿瘤浸润免疫细胞中的DNA损伤未见升高。当RT前后均施加TTFields时,肿瘤中显示出DNA损伤增加。
结论:我们的研究结果表明,短暂暴露于TTFields可使GBM放射敏感化,且时序和顺序对于最大化该效应至关重要。
查看英文原文 English abstract
Background: Tumor Treating Fields (TTFields) therapy, which delivers low-intensity, alternating electric fields to disrupt cellular processes crucial for cancer cell division, is an FDA-approved modality for patients with newly diagnosed and recurrent glioblastoma (GBM). Beyond its established antimitotic effects, TTFields have been shown to interfere with DNA damage repair pathways, suggesting potential synergy with radiation therapy (RT). In this study, we explored whether brief exposure to TTFields can sensitize GBM cells to radiation.
Methods: U87-MG GBM cells were exposed to 2 Gy radiation, to TTFields (200 kHz, 2h), or to TTFields followed by radiation, and colony formation was tested. RNA extracts from control and TTFields-treated cells were examined by PCR for changes in DNA damage response genes. Western blot analyses assessed changes in protein levels of DNA repair genes FANCD2, FANCJ, FANCA, FANCB, BRCA1, and BRCA2. C57BL/6 mice were intracranially implanted with GL261-mCherry glioma cells and tumor growth was confirmed by MRI on day 17 post-implantation. Mice were then randomized into treatment groups receiving TTFields (200 kHz), RT (6 Gy) or the two modalities together with various sequencing: TTFields pre-RT, TTFields post-RT, or TTFields both pre- and post-RT. Tumors were harvested for single-cell suspension preparation, and DNA damage was quantified by flow cytometry using gammaH2AX staining.
Results: Short exposure to TTFields alone was insufficient to reduce colony formation of the cells. However, when TTFields were applied prior to RT, colony formation was decreased relative to that for RT alone. The TTFields-treated cells demonstrated downregulation of genes and proteins associated with DNA damage repair. In mice, while TTFields post-RT had negligible effects on tumor DNA damage levels relative to application of RT alone, TTFields prior to RT resulted in increased DNA damage and reduced expression of DNA repair protein within tumor cells, with no elevation of DNA damage in tumor infiltrating immune cells. When TTFields were applied both pre- and post-RT, increased DNA damage was demonstrated in the tumor.
Conclusions: Our findings demonstrate that GBM can be radiosensitized by short exposure to TTFields, and that timing and sequencing are important for maximizing the effect.
利益披露 Disclosure
A. Klein-Goldberg,
Novocure Ltd Employment, Stock.
T. Voloshin,
Novocure Ltd Employment, Stock.
A. Meir,
Novocure Ltd Employment, Stock.
E. Zemer-Tov,
Novocure Ltd Employment, Stock.
H. Ene,
Novocure Ltd Employment, Stock.
L. Lifshitz,
Novocure Ltd Employment, Stock.
K. Wainer-Katsir,
Novocure Ltd Employment, Stock.
A. Haber,
Novocure Ltd Employment, Stock.
M. Giladi,
Novocure Ltd Employment, Stock, Other Intellectual Property.
U. Weinberg,
Novocure Ltd Employment, Stock, Other Intellectual Property.
Y. Palti,
Novocure Ltd Stock, Other Intellectual Property.